Non-Oncology Precision Medicine Market Trends

Segmentation Analysis:

The Non-Oncology Precision Medicine Market is segmented by Product Type, Application, End-use, Ecosystem, Technology, Geography. We are analyzing the market of these segments to identify which segment is the largest now and in the future, which segment has the highest growth rate, and the segment which offers the opportunity in the future.

• Based on Product Type the market is segmented as, Diagnostics, Genetic Tests, Biomarker Based Tests, Others, Therapeutics
• Based on Application the market is segmented as, Oncology, CNS, Immunology, Respiratory, Infectious Diseases, Respiratory Infections, Gastrointestinal Infections, Sexually Transmitted Infections, Others, Neurology, Neurodegenerative Disorders, Neuropsychiatric Disorders, Others, Cardiovascular, Cardiac Myopathies and Arrhythmia, Others, Lifestyle and Endocrinology, Gastroenterology, Others
• Based on End-use the market is segmented as, Hospitals, Diagnostic Centers, Research & Academic Institutes, Others
• Based on Ecosystem the market is segmented as, Applied Sciences, Genomics
• Based on Technology the market is segmented as, Polymerase Chain Reaction (PCR), Precision Medicine Next-Generation Sequencing (PM NGS), Genome Editing, Other Technologies, Pharmacogenomics, Other Applied Sciences, Precision Diagnostics, Molecular Diagnostics (MDx), Medical Imaging, Digital Health and Information Technology, Clinical Decision Support Systems (CDSS), Big Data Analytics, IT Infrastructure, Genomics Informatics, In-Silico Informatics, Mobile Health, Precision Therapeutics, Clinical Trials, Cell Therapy, Drug Discovery and Research, Gene Therapy
• Based on Geography the market is segmented as, North America, U.S., Canada, Europe, U.K., Germany, France, Asia-Pacific, China, India, Japan, South Korea, Malaysia, Philippines, Latin America, Brazil, Rest of Latin America, Middle East & Africa (MEA), GCC, North Africa, South Africa, Rest of the Middle East & Africa